Disease areas

Anita 4

Obesity

Obesity and overweight is a complex chronic disease that requires long term management. More than 220 complications and co-morbidities, including cardiovascular disease, liver disease, type 2 diabetes, kidney disease, and neuroinflammation are associated with obesity.

  • Learn about obesity
  • AR Mike Sherels With Child 2

    Rare diseases

    We are focused on two very different rare diseases where peptide-based therapies have potential to address significant unmet needs and improve lives: congenital hyperinsulinism (CHI) and short bowel syndrome (SBS)

  • Learn about CHI
  • Learn about SBS
  • Zealand Pharma 1102

    Chronic inflammation

    Chronic inflammation plays a role in many diseases and conditions that are leading causes of death worldwide.

  • Learn about Chronic inflammation
  • Anita 4 AR Mike Sherels With Child 2 Zealand Pharma 1102

    Patient stories

    How a chair made me see my life differently: J's Story

    • Obesity

    J’s story reflects the realities of living with obesity, from navigating care to finding what works in daily life, and how health is built through practical choices over time.

    Read my story

    The importance of early detection: Brooke & Kaiden’s journey with CHI

    • Congenital Hyperinsulinism

    Brooke learned early in Kaiden’s life that he was living with congenital hyperinsulinism (CHI), but not from doctors. Instead, she recognized the signs herself, drawing on her own experience with diabetes. This is why today, Brooke can manage Kaiden's CHI and reminds us why early detection is critical.

    Read my story

    A story without a finish line: Jess’ lifelong journey with obesity

    • Obesity

    Jess's journey with obesity has included both setbacks and growth, showing how persistence - not perfection - shapes an ongoing path toward better health.

    Read my story

    Crosby was born with CHI

    • Congenital Hyperinsulinism

    Julie and her husband, knew during pregnancy that Crosby, would be born with congenital hyperinsulinism (CHI): an ultra-rare genetic disorder that causes the insulin cells of the pancreas, called beta cells, to secrete too much insulin. The disorder may cause Crosby to have cognitive and physical disabilities if not treated adequately.

    Read my story

    Marianne lives with Short Bowel Syndrome

    • Short Bowel Syndrome

    Marianne was diagnosed with cancer of the small intestine and became a short bowel patient. Today, she manages to live a life on home parenteral nutrition and works as a pastor.

    Read my story

    Learning to live with a body that's always negotiating

    • Obesity

    Anita's experience with obesity — shaped by family culture, bariatric surgery, and a cancer diagnosis — shows how managing weight is an ongoing, evolving process that requires flexibility and self-compassion.

    Read my story

    Mike gets back in the game while living with SBS

    • Short Bowel Syndrome

    Dependent on parenteral support to survive, Mike must connect to infusion equipment for eight hours a day, six days a week. Reducing the complexity – and time spent – for parenteral support enabled this driven college football coach to get back in the game.

    Read my story

    Will works to reduce his need for parenteral support

    • Short Bowel Syndrome

    After a stomach pain and a black out in his home, then 13-year old Will was rushed to a local hospital in New Jersey, where the doctors discovered a volvulus and most of his small intestine was removed.

    Read my story

    I hear from our employees every day how important it is to them that the work we do contributes to making a difference in peoples lives.

    Christina Sonnenborg Bredal

    Chief People Officer

    Christina ALR0693 V2

    Latest news

    View all news
    • COMPANY ANNOUNCEMENT

      Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)

      READ MORE
    • COMPANY ANNOUNCEMENT

      Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

      READ MORE
    • COMPANY ANNOUNCEMENT

      Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)

      READ MORE
    • COMPANY ANNOUNCEMENT

      Zealand Pharma increases its share capital as a result of the exercise of employee warrants

      READ MORE